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Introduction. Machado-Joseph disease (MJD) is a neurodegenerative disorder with an autosomal dominant hereditary pattern. MJD 
is caused by an expansion of a CAG repeat track in the ATXN3 gene. Previous studies show that age of onset (AO) of the disease 
is inversely correlated with the number of CAG repeats in the expanded allele. However, only between 40 to 68% of AO variation 
can be explained by this factor, leaving at least 30% of variation entirely unaccounted for. Taking into consideration scientific 
support for a shared molecular mechanism for all inherited genetic neurodegenerative diseases, the key to describing this variation 
could lie in the molecular biology of other, related diseases. Recently, a pathway of protein degradation via Gp78 has been 
identified as a molecular link between MJD and amyotrophic lateral sclerosis (ALS). In 2011, a hexanucleotide repeat expansion in 
C9orf72 was identified as the etiology in a significant portion of ALS patients as well as patients of frontotemporal dementia (FTD) 
and those affected by comorbid ALS-FTD. Objective. Investigate the occurrence and modifying effects of the C9orf72 
hexanucleotide expansion in MJD patients. Methods. A total of 80 MJD patients with a molecular diagnosis and 100 controls with 
no history of ataxia were recruited at the Hospital de Clínicas de Porto Alegre and will be included in the study.At first, a reliable 
protocol for genotyping alleles within normal range of C9Orf72 was introduced using conventional PCR with a fluorescent primer in 
order to select candidate expansion carriers. Expanded alleles will be genotyped via repeat-primed PCR (RP-PCR), a protocol 
 
  
designed to identify very large expansions. MJD patients will be divided into two groups based on AO (early- and late-onset) for the 
purposes of analysis. Results. Up to date, 34 samples have been analyzed (23 MJD and 11 controls). Two distinct alleles were 
observed in 20 samples (12 MJD and 8 controls). Interestingly, 17 samples presented only 1 hexanucleotide expansion, a genotype 
either absent or rare in previously studied populations. Conclusion. Protocol for a complete analysis was fully established and 
analyses will continue until we reach our proposed cohort size. However, data generated is still too preliminary to draw any further 
conclusions. Keywords: Machado-Joseph Disease, modifying factors, C9ORF72  
